OSCR (Oscar Health) Research & Development: $0 Mil (TTM As of Mar. 2026)


OSCR Oscar Health Inc OSCR
76 GF Score
Price $30.68
GF Value $21.26
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Oscar Health Research & Development?

Oscar Health OSCR -0.44% 76 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates OSCR with a GF Score™ of 76/100 and a GF Value™ of $21.26 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Oscar Health's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Oscar Health  (NYSE:OSCR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Oscar Health Research & Development Related Terms

Oscar Health Research & Development Historical Data

* Premium members only.

The historical data trend for Oscar Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oscar Health Research & Development Chart

Oscar Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Oscar Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSCR
76GF Score
Oscar Health Inc OSCR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oscar Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Oscar Health (OSCR) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Oscar Health and its competitors.
Is Oscar Health's Research & Development too high?
Oscar Health's current Research & Development is $0 Mil. Overall, Oscar Health has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's Research & Development compare to MOH and ALHC?
Oscar Health's Research & Development of $0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Plans company?
A good Research & Development depends on the Healthcare Plans industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Oscar Health and its competitors. Oscar Health's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (OSCR) is currently considered Significantly Overvalued. The stock's GF Value™ is $21.26, compared to a current price of $30.68 — trading 44.3% above its estimated fair value. The current Research & Development is $0 Mil. Oscar Health's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Oscar Health (OSCR), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oscar Health (OSCR) Overvalued in 2026?

Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued. The current stock price of $30.68 is trading 44.3% above its estimated GF Value™ of $21.26. GuruFocus considers Oscar Health to be Significantly Overvalued.

Key valuation signals for OSCR:

  • Research & Development: $0 Mil
  • GF Value™: $21.26 vs. price of $30.68 (44.3% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oscar Health Business Description

Address 75 Varick Street, 5th Floor, New York, NY, USA, 10013
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
76GF Score

Get the complete analysis for OSCR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.68
Price
$21.26
GF Value